Search

News archive - 9th Call webinars by IMI - The Innovative Medicines Initiative

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

IMI supports research projects in the areas of safety and efficacy, knowledge management and education and training. Projects are selected through open calls for proposals.
The research consortia participating in IMI projects consist of:

  • large biopharmaceutical companies that are members of EFPIA,
  • and a variety of other partners, such as:
  • small- and medium-sized enterprises,
  • patients' organisations,
  • universities and other research organisations,
  • hospitals,
  • regulatory agencies,
  • any other industrial partners.
Entities both from European Member States or countries associated with the  Seventh Framework Programme can participate in an IMI JU collaborative project.

IMI will hold webinars on all 9th Call topics as well as its rules and procedures in July 2013.

Start date: 01/07/2013
End date: 15/07/2013
 
All topic webinars will feature a presentation of the Call topic by the EFPIA topic coordinator as well as time for questions and answers. The webinars will therefore represent an excellent opportunity to learn more about the topics, interact directly with the topic coordinators, and get in touch with potential project partners. The webinar on IMI’s rules and procedures will include presentations of IMI's rules and procedures, its intellectual property policy, and tips on the preparation of an Expression of Interest.

Registration

Registration is free but obligatory. To sign up, complete and submit the registration form for the webinar(s) you wish to attend. As places are limited, early registration is recommended.

Webinar schedule

Developing innovative therapeutic interventions against physical frailty and sarcopenia (ITI-PF&S) as a prototype geriatric indication
Monday 1 July, 15:00 CEST (Central European Summer Time / Brussels time)
Register

Driving re-investment in R&D and responsible use of antibiotics (ND4BB topic 4)
Wednesday 3 July, 13:00 CEST (Central European Summer Time / Brussels time)
Register

WEBAE – Leveraging emerging technologies for pharmacovigilance
Friday 5 July, 10:00 CEST (Central European Summer Time / Brussels time)
Register

Clinical development of antibacterial agents for Gram-negative antibiotic resistant pathogens (ND4BB topic 5)
Tuesday 9 July, 15:00 CEST (Central European Summer Time / Brussels time)
Register

IMI's rules & procedures
Monday 15 July, 11:00 CEST (Central European Summer Time / Brussels time)
Register

Technical points

To follow the presentation fully, registered participants should both:

  • dial the number given in their confirmation e-mail using a landline or mobile phone AND
  • click on the link in the confirmation e-mail.

You should click on the link to join the webinar a few minutes before the start – this will give your computer time to download the software. Note that it will not be possible to follow the audio part or of the webinar over your computer (e.g. via your computer’s speakers or a headset that is connected to your computer). To follow the audio part of the webinar, you must dial in with a landline or mobile phone. During the webinar, all participants except the presenters will be in mute mode. However, you will be able to send questions via the chat box and raise your hand to attract the organiser's attention.

Country
Belgium
Geographical focus
  • FP7
  • Western Balkans
Scientifc field / Thematic focus
  • Medical and Health Sciences
Related articles:

Entry created by Desiree Pecarz on June 28, 2013
Modified on June 28, 2013